Galmed Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CVI Investments, Inc.(9.9%),Heights Capital Management, Inc.(9.9%)
Feb 14 14:18 ET
Galmed Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%), etc.
Feb 14 09:57 ET
Galmed Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Allen Baharaff(6.2%),G. Yarom Medical Research Ltd.(4.5%)
Feb 12 16:22 ET
Galmed Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-CVI Investments, Inc.(9.9%),Heights Capital Management, Inc.(9.9%)
Jul 21, 2023 10:12 ET
Galmed Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF Partners L.P.(6.9%),BVF Inc.(6.9%), etc.
Feb 14, 2023 12:03 ET
Galmed Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Allen Baharaff(17.3%),G. Yarom Medical Research Ltd.(13.6%)
Feb 7, 2023 16:15 ET
Galmed Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nantahala Capital Management, LLC(1.2%),Wilmot B. Harkey(1.2%), etc.
Feb 14, 2022 08:14 ET
Galmed Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Allen Baharaff(16.9%),G. Yarom Medical Research Ltd.(13.6%)
Feb 11, 2022 16:30 ET
Galmed Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ibex Investors LLC(1.4%),Justin B. Borus(1.4%), etc.
Jan 27, 2022 16:32 ET
Galmed Pharmaceuticals | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Feb 16, 2021 06:23 ET
Galmed Pharmaceuticals | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Feb 12, 2021 16:30 ET
Galmed Pharmaceuticals | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Feb 12, 2021 16:13 ET
Galmed Pharmaceuticals | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Jan 15, 2021 11:16 ET
Galmed Pharmaceuticals | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Jul 28, 2020 15:22 ET
Galmed Pharmaceuticals | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Feb 14, 2020 15:18 ET
Galmed Pharmaceuticals | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Feb 13, 2020 16:30 ET
Galmed Pharmaceuticals | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Feb 13, 2020 10:11 ET
Galmed Pharmaceuticals | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Feb 14, 2019 16:47 ET
Galmed Pharmaceuticals | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Feb 14, 2019 16:34 ET
Galmed Pharmaceuticals | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Feb 11, 2019 16:30 ET
No Data
No Data